SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,458 | +852.0% | 643,897 | +6083.0% | 0.00% | – |
| Q2 2023 | $12,443 | +72.9% | 10,414 | 0.0% | 0.00% | – |
| Q1 2023 | $7,195 | -44.7% | 10,414 | -44.9% | 0.00% | – |
| Q4 2022 | $13,000 | -35.0% | 18,914 | 0.0% | 0.00% | – |
| Q3 2022 | $20,000 | +53.8% | 18,914 | -1.3% | 0.00% | – |
| Q2 2022 | $13,000 | -18.8% | 19,164 | -2.5% | 0.00% | – |
| Q1 2022 | $16,000 | -61.9% | 19,664 | -23.5% | 0.00% | – |
| Q4 2021 | $42,000 | -32.3% | 25,714 | -0.4% | 0.00% | – |
| Q3 2021 | $62,000 | +10.7% | 25,815 | +21.1% | 0.00% | – |
| Q2 2021 | $56,000 | +60.0% | 21,325 | +203.3% | 0.00% | – |
| Q1 2021 | $35,000 | +94.4% | 7,032 | -39.7% | 0.00% | – |
| Q4 2020 | $18,000 | +63.6% | 11,671 | -0.3% | 0.00% | – |
| Q3 2020 | $11,000 | +266.7% | 11,704 | +282.0% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 3,064 | +48.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 2,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |